Evident Vascular

Focus: Evident Vascular is a cardiovascular biotechnology company specializing in intravascular ultrasound (IVUS) technology, headquartered in San Jose, CA. The company operates as a focused device/diagnostic player in the interventional cardiology space.

Cardiovascular

Profile data last refreshed 2h ago · AI intelligence enriched 2w ago

Open Jobs

Should You Work at Evident Vascular?

AI assessment

Evident Vascular presents a high-risk, high-optionality bet suited only for early-career or specialist professionals comfortable with significant execution uncertainty in exchange for equity upside in a focused cardio-device niche.

Why Work Here

Specialized focus on intravascular ultrasound positions you at the intersection of cardiology innovation and diagnostic imaging, a high-value clinical niche

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Open Jobs (1)

Accountant

Remote

1mo ago

Interview Prep Quick Facts

Open Roles: 1 active job

Hiring Trend

Help build intelligence for Evident Vascular

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Watch Out For

Minimal public financial data (no revenue, funding, or employee count disclosed) suggests either stealth-stage operations or limited market visibility, creating uncertainty around runway and growth trajectory
Only 1 active job opening indicates either low hiring velocity or severely constrained headcount, suggesting limited internal mobility and potential resource constraints
Zero clinical trials in pipeline and no disclosed products indicate pre-commercialization stage with longer time-to-validation and revenue inflection